| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.009 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |